Progress in Synthesis and Bioactivity Evaluation of Pyrazoloquinazolines
Authors:
- 13 February 2020
- journal article
- review article
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 17 (2) , 104-113
Abstract
Background: This paper reviews the research progress of pyrazoloquinazolines which widely used in the field of medicine and pesticide in recent years. Five types of pyrazoloquinazolines are introduced: pyrazolo [4,3-h]quinazolines, pyrazolo[1,5-c]quinazolines, pyrazolo[4,3-f]quinazolines, pyrazolo[1,5-a] quinazolines , pyrazolo[1,5-b]quinazolines, and their new progress in the synthesis methods and treatment of diseases. Methodology: The derivatives of pyrazoloquinazolines exhibit a wide range of pharmacological properties such as antibacterial, anticancer, antioxidants, anti-inflammatory, anti-diabetic, antiviral activities. Consequently, their syntheses have attracted significant interest. Various methodologies have been developed for the synthesis and functionalization of these class of compounds. Conclusion: In the present article, the relevant and recent advances in the field will be briefly covered.Keywords
Funding Information
- National Natural Science Foundation of China (21305051)
This publication has 42 references indexed in Scilit:
- Anti‐tumour efficacy on glioma models of PHA‐848125, a multi‐kinase inhibitor able to cross the blood–brain barrierBritish Journal of Pharmacology, 2013
- Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure–affinity relationships and molecular modeling studiesBioorganic & Medicinal Chemistry, 2013
- Carbo[3 + 3] cyclocondensation reactions. A new method for the synthesis of tetrahydropyrazolo[1,5-b]quinazolines and tetrahydropyrazolo[4,5-b]quinolinesChemistry of Heterocyclic Compounds, 2012
- Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignanciesInvestigational New Drugs, 2011
- Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and DockingInternational Journal of Molecular Sciences, 2010
- Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor EfficacyMolecular Cancer Therapeutics, 2010
- Synthesis of some new pyrazoloquinazolinone and quinazolinone derivativesJournal of Heterocyclic Chemistry, 2006
- Synthesis and Binding Activity of Some Pyrazolo[1,5-c]quinazolines as Tools To Verify an Optional Binding Site of a Benzodiazepine Receptor LigandJournal of Medicinal Chemistry, 1996